Transaction in Own Shares

AI SummaryClose X

RTW Biotech Opportunities bought back 350,000 ordinary shares on 18 November 2026 at $2.43 per share, to be held in treasury; following settlement issued share capital is 345,967,440 with 29,127,617 shares in treasury (no voting rights), leaving total voting rights of 316,839,823. The repurchase was made under the June 2026 AGM authority permitting repurchases up to 14.99% of shares, the company states it will not pay a price that equates to a premium to net asset value and currently intends to hold repurchased shares in treasury.

Disclaimer*

UK 100

Latest directors dealings